Miguel Dias

Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing

Emma Borràs, Ismael Jurado, Imma Hernán et al. · BMC Cancer · 2011 · 92 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Detection of Genomic Variations in BRCA1 and BRCA2 Genes by Long-Range PCR and Next-Generation Sequencing

Imma Hernán, Emma Borràs, Miguel Dias et al. · Journal of Molecular Diagnostics · 2012 · 49 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Liquefied Wood as Inexpensive Precursor-Feedstock for Bio-Mediated Incorporation of (R)-3-Hydroxyvalerate into Polyhydroxyalkanoates

Martin Koller, Miguel Dias, Alejandra Rodríguez‐Contreras et al. · Materials · 2015 · 47 citations · Full text

Life Sciences, Bioengineering, Biotechnology +17

Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population.

Elena Millá, Begoña Mañé, Susana Duch et al. · PubMed · 2013 · 32 citations · Full text

Life Sciences, Genetics, Ophthalmology +15

Detection of novel mutations that cause autosomal dominant retinitis pigmentosa in candidate genes by long-range PCR amplification and next-generation sequencing.

Miguel Dias, Imma Hernán, Beatriz Pascual et al. · PubMed · 2013 · 24 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15